Uncategorized

Micro-X (ASX:MX1) extends contract with U.S. DHS to test self-screening modules at an airport. In response, Micro-X Inc. Chief Executive Officer of Americas and Chief Scientist, Brian Gonzales, commented: “This contract extension fully funds us to build and test the design of a self-screening checkpoint in real airports, demonstrating the improvements and refining the design

Stocks were mixed Friday as traders assessed the latest corporate earnings results, and the Dow Jones Industrial Average stretched its winning streak to 10 sessions, a feat not seen for the index since August 2017. The 30-stock Dow climbed 2.51 points, or 0.01 per cent, to close at 35,227.69 . The S&P 500 added 0.03

Many investors entered the second-quarter earnings season expecting the worst for regional banks. But that didn’t materialise in the results released this week—at least not for the bigger players. Many banks, including KeyCorp, Western Alliance Bancorp, and Zions Bancorp, posted sharp profit declines. But their deposits were stable or higher compared with the first quarter,

In the ongoing economic battle between Russia and the West, Moscow has managed to breach the Western-imposed price cap on its most prized crude oil, signalling a significant victory for the Kremlin. The price cap, introduced last December by the U.S. and its allies as part of a pressure campaign against Russia following its invasion

Magnis Energy Technologies Limited (ASX:MNS) Managing Director (US) Hoshi Daruwalla and Technical Advisory Committee members Dr Michael Osborne and Wade Guindy discuss progress, focusing on the company’s lithium-ion battery manufacturing plant, iM3NY. Paul Sanger: We’re talking today with Magnis Energy Technologies (ASX:MNS). If you don’t know the company, the ASX code is “MNS”, and it

Moderna is setting its sights on a groundbreaking “superjab” that could protect against the most prevalent respiratory viruses, including Covid-19, influenza (flu), and respiratory syncytial virus (RSV). As the Covid-19 pandemic gradually subsides, Moderna is repositioning its business strategy to address the ongoing threat of respiratory illnesses. While Covid-19 thrust Moderna and its mRNA vaccine

The rising trend of remote work is reshaping the landscape of Australian office spaces, as corporates grapple with the question of how much real estate they truly need in a work-from-home world. This paradigm shift is contributing to a surge in office vacancies, leaving landlords under increasing pressure. Recent research from real estate firm JLL